Abstract
Depression is a prevalent mental disorder, affecting approximately 300 million peopleworldwide. Despite decades of research into the underlying mechanisms of depression, a consensusremains elusive. Recent studies have implicated changes in oligodendrocytes and myelin in the pathogenesisof depression. Conventional antidepressants may alleviate symptoms within weeks of use,but approximately one-third of patients do not respond to them. Ketamine exhibits rapid and sustainedantidepressant effects in treatment-resistant patients with depression. Given the associationbetween reduced myelination and depression pathology, alterations in myelination may be a keymechanism underlying ketamine's prolonged antidepressant effects. However, the exact role of myelinationin ketamine's sustained antidepressant effects remains unclear. In this review, we summarizethe relationship between demyelination and depression and discuss the potential mechanisms bywhich ketamine may exert its antidepressant effects by repairing myelin damage, offering new insightsinto the role of myelination in antidepressant mechanisms.
Keywords:Arketamine, enantiomer, esketamine, ketamine, depression, myelination, oligodendrocyte.
Current Neuropharmacology
Title:Myelin Repair as a Novel Mechanism for Ketamine’s Sustained Antidepressant Effects
Volume: 23Issue: 8
Author(s):Sen Wang, Chaoli Huang, Mengyu Wang, Lingxiao Di, Cunming Liu, Kenji Hashimoto*Chun Yang*
Affiliation:
- Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan
- Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
Keywords:Arketamine, enantiomer, esketamine, ketamine, depression, myelination, oligodendrocyte.
Abstract: Depression is a prevalent mental disorder, affecting approximately 300 million peopleworldwide. Despite decades of research into the underlying mechanisms of depression, a consensusremains elusive. Recent studies have implicated changes in oligodendrocytes and myelin in the pathogenesisof depression. Conventional antidepressants may alleviate symptoms within weeks of use,but approximately one-third of patients do not respond to them. Ketamine exhibits rapid and sustainedantidepressant effects in treatment-resistant patients with depression. Given the associationbetween reduced myelination and depression pathology, alterations in myelination may be a keymechanism underlying ketamine's prolonged antidepressant effects. However, the exact role of myelinationin ketamine's sustained antidepressant effects remains unclear. In this review, we summarizethe relationship between demyelination and depression and discuss the potential mechanisms bywhich ketamine may exert its antidepressant effects by repairing myelin damage, offering new insightsinto the role of myelination in antidepressant mechanisms.
Export Options
About this article
Cite this article as:
Wang Sen, Huang Chaoli, Wang Mengyu, Di Lingxiao, Liu Cunming, Hashimoto Kenji*, Yang Chun*, Myelin Repair as a Novel Mechanism for Ketamine’s Sustained Antidepressant Effects, Current Neuropharmacology 2025; 23 (8) .https://dx.doi.org/10.2174/011570159X349856241213144902
DOI https://dx.doi.org/10.2174/011570159X349856241213144902 | Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher | Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances in Neuroinflammation and Neuroprotection: Mechanisms and Therapeutic Frontiers
It offers a comprehensive exploration of neuroinflammatory and neuroprotective pathways that play central roles in a range of neurological disorders, including stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This issue invites research on the cellular and molecular mechanisms driving neuroinflammation, such as the roles of ...read more
Advances in paediatric and adult brain cancers: emerging targets and treatments
Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more
Cannabinoids in Health and Disease.
The role of cannabinoids in human physiology and disease has become a dynamic and rapidly evolving field of research, offering new insights into the potential of these compounds. With advancements in neuropharmacology and clinical trials, cannabinoids are now at the forefront of innovative approaches to treat several conditions. This special ...read more
Cannabis in Health and Disease
Cannabis-based products span a history of over 4,000 years, with their regular purposes in numerous religious rituals, traditional systems of medicine, cosmetics, and hedonic activities. The discovery and cloning of cannabinoid receptors in mammalian tissues provided direct evidence of the physiological significance of targeting these receptors with endogenously synthesized and ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
[8]ページ先頭